Thank you.
Mr. Wright, at the beginning of your presentation, you said that the CDR was an efficient organization. We understand that it is not our job to make recommendations on how to improve the understanding and efficiency of the CDR. However, witnesses have told us the exact opposite. Some even told us that the CDR should not even exist at all and that it has not improved the situation. Others chose their words more carefully.
Is it true that every single first category drugs and 75% of natural drugs were rejected when they were evaluated by the CDR?
Quebec has its own process. It seems to be much more open to these types of products than the CDR. Does this mean that our role is to make sure a drug is effective, but at a reasonable and fair cost? Does it then follow that this is not Quebec's priority? If you want to give patients what they need to improve their quality of life, don't you think that you are missing the main objective, which is to make the best products available to patients?
I would like you to answer these questions, Mr. Wright.